Logo image of HCO.PA

HIGH CO (HCO.PA) Stock Fundamental Analysis

EPA:HCO - FR0000054231 - Common Stock

3.58 EUR
-0.02 (-0.56%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

5

HCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Media industry. HCO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HCO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year HCO was profitable.
HCO had a positive operating cash flow in the past year.
Each year in the past 5 years HCO has been profitable.
HCO had a positive operating cash flow in each of the past 5 years.
HCO.PA Yearly Net Income VS EBIT VS OCF VS FCFHCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1.2 Ratios

With a decent Return On Assets value of 3.61%, HCO is doing good in the industry, outperforming 67.69% of the companies in the same industry.
HCO's Return On Equity of 8.02% is fine compared to the rest of the industry. HCO outperforms 61.54% of its industry peers.
HCO's Return On Invested Capital of 8.20% is fine compared to the rest of the industry. HCO outperforms 73.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HCO is above the industry average of 8.08%.
Industry RankSector Rank
ROA 3.61%
ROE 8.02%
ROIC 8.2%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
HCO.PA Yearly ROA, ROE, ROICHCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

HCO has a Profit Margin of 5.10%. This is in the better half of the industry: HCO outperforms 67.69% of its industry peers.
HCO's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 7.91%, HCO is doing good in the industry, outperforming 61.54% of the companies in the same industry.
HCO's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 39.38%, HCO is doing worse than 61.54% of the companies in the same industry.
In the last couple of years the Gross Margin of HCO has declined.
Industry RankSector Rank
OM 7.91%
PM (TTM) 5.1%
GM 39.38%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
HCO.PA Yearly Profit, Operating, Gross MarginsHCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

HCO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HCO has been reduced compared to 1 year ago.
HCO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HCO has been reduced compared to a year ago.
HCO.PA Yearly Shares OutstandingHCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Yearly Total Debt VS Total AssetsHCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.82 indicates that HCO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.82, HCO is doing good in the industry, outperforming 64.62% of the companies in the same industry.
The Debt to FCF ratio of HCO is 0.25, which is an excellent value as it means it would take HCO, only 0.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.25, HCO belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
HCO has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HCO (0.04) is better than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 1.82
ROIC/WACC1.11
WACC7.4%
HCO.PA Yearly LT Debt VS Equity VS FCFHCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

HCO has a Current Ratio of 1.20. This is a normal value and indicates that HCO is financially healthy and should not expect problems in meeting its short term obligations.
HCO has a Current ratio of 1.20. This is in the better half of the industry: HCO outperforms 67.69% of its industry peers.
A Quick Ratio of 1.20 indicates that HCO should not have too much problems paying its short term obligations.
HCO has a Quick ratio of 1.20. This is in the better half of the industry: HCO outperforms 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
HCO.PA Yearly Current Assets VS Current LiabilitesHCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

The earnings per share for HCO have decreased strongly by -29.18% in the last year.
Measured over the past years, HCO shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.40% on average per year.
HCO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.64%.
HCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)-29.18%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-76.25%
Revenue 1Y (TTM)0.64%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%0.43%

3.2 Future

HCO is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.54% yearly.
The Revenue is expected to decrease by -1.06% on average over the next years.
EPS Next Y-29.51%
EPS Next 2Y-15.55%
EPS Next 3Y-8.54%
EPS Next 5YN/A
Revenue Next Year-12.38%
Revenue Next 2Y-2.26%
Revenue Next 3Y-1.06%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCO.PA Yearly Revenue VS EstimatesHCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
HCO.PA Yearly EPS VS EstimatesHCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

HCO is valuated reasonably with a Price/Earnings ratio of 9.18.
80.00% of the companies in the same industry are more expensive than HCO, based on the Price/Earnings ratio.
HCO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
HCO is valuated correctly with a Price/Forward Earnings ratio of 16.49.
HCO's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of HCO to the average of the S&P500 Index (22.54), we can say HCO is valued slightly cheaper.
Industry RankSector Rank
PE 9.18
Fwd PE 16.49
HCO.PA Price Earnings VS Forward Price EarningsHCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HCO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HCO is cheaper than 95.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.04
EV/EBITDA -0.05
HCO.PA Per share dataHCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

HCO has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as HCO's earnings are expected to decrease with -8.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.55%
EPS Next 3Y-8.54%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.10%, HCO is a good candidate for dividend investing.
HCO's Dividend Yield is rather good when compared to the industry average which is at 5.80. HCO pays more dividend than 92.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, HCO pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.1%

5.2 History

The dividend of HCO has a limited annual growth rate of 5.90%.
Dividend Growth(5Y)5.9%
Div Incr Years1
Div Non Decr Years1
HCO.PA Yearly Dividends per shareHCO.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

HCO pays out 74.33% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of HCO has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP74.33%
EPS Next 2Y-15.55%
EPS Next 3Y-8.54%
HCO.PA Yearly Income VS Free CF VS DividendHCO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Dividend Payout.HCO.PA Dividend Payout, showing the Payout Ratio.HCO.PA Dividend Payout.PayoutRetained Earnings

HIGH CO

EPA:HCO (9/10/2025, 7:00:00 PM)

3.58

-0.02 (-0.56%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-29 2025-04-29
Earnings (Next)09-10 2025-09-10
Inst Owners16.89%
Inst Owner ChangeN/A
Ins Owners16.32%
Ins Owner ChangeN/A
Market Cap73.25M
Analysts77.5
Price Target4.31 (20.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.1%
Yearly Dividend0.28
Dividend Growth(5Y)5.9%
DP74.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.42%
PT rev (3m)21.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.13%
EPS NY rev (3m)-15.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-13.8%
Revenue NY rev (3m)-9.21%
Valuation
Industry RankSector Rank
PE 9.18
Fwd PE 16.49
P/S 0.5
P/FCF 3.04
P/OCF 2.98
P/B 0.79
P/tB 3.92
EV/EBITDA -0.05
EPS(TTM)0.39
EY10.89%
EPS(NY)0.22
Fwd EY6.07%
FCF(TTM)1.18
FCFY32.9%
OCF(TTM)1.2
OCFY33.58%
SpS7.15
BVpS4.55
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.61%
ROE 8.02%
ROCE 11.25%
ROIC 8.2%
ROICexc 37.88%
ROICexgc N/A
OM 7.91%
PM (TTM) 5.1%
GM 39.38%
FCFM 16.46%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
ROICexc(3y)33.2%
ROICexc(5y)64.31%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.94%
ROCE(5y)13.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y5.39%
ROICexc growth 5Y4.92%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.18
Cap/Depr 7.6%
Cap/Sales 0.34%
Interest Coverage 250
Cash Conversion 135.83%
Profit Quality 322.93%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 1.82
F-Score6
WACC7.4%
ROIC/WACC1.11
Cap/Depr(3y)22.18%
Cap/Depr(5y)23.34%
Cap/Sales(3y)0.82%
Cap/Sales(5y)1.08%
Profit Quality(3y)322.39%
Profit Quality(5y)287.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.18%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-76.25%
EPS Next Y-29.51%
EPS Next 2Y-15.55%
EPS Next 3Y-8.54%
EPS Next 5YN/A
Revenue 1Y (TTM)0.64%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%0.43%
Revenue Next Year-12.38%
Revenue Next 2Y-2.26%
Revenue Next 3Y-1.06%
Revenue Next 5YN/A
EBIT growth 1Y-29.33%
EBIT growth 3Y-13.67%
EBIT growth 5Y-7.51%
EBIT Next Year1.49%
EBIT Next 3Y1.31%
EBIT Next 5YN/A
FCF growth 1Y122.14%
FCF growth 3Y35.54%
FCF growth 5Y0.35%
OCF growth 1Y92.44%
OCF growth 3Y31.82%
OCF growth 5Y-1.02%